IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, presenting promising enhancements throughout numerous professional medical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, extra trusted substitute for the